World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

LEFT ATRIAL THROMBUS RESOLUTION WITH RIVAROXABAN IN ATRIAL FIBRILLATION: A CASE REPORT

Sergio Agosti*, MD, PhD, Laura Casalino, MD, PhD, MD, Eugenia Rota, MD, Lorella Pisano, MD, Gabiele Zaccone, MD and Cuozzo Enrico, MD

ABSTRACT

Background: atrial fibrillation is a major cause of thrombus formation within the left atrium (LA) and left atrial appendage (LAA). In patients with LA/LAA thrombus by transesophageal echocardiography, current guidelines recommend vitamin K antagonist treatment. At present, data on the efficacy of direct oral anticoagulants in the resolution of LA/LAA thrombi are scarce. Case presentation: we here describe a case of LA thrombus resolution in a patient treated with rivaroxaban. Conclusions: our case report adds to the evidence that rivaroxaban is effective in LA thrombus resolution.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR